Innospec Inc. (IOSP) AI Stock Analysis

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals internationally. Its operations span three main segments: Fuel Specialties, Performance Chemicals, and Oilfield Services. Fuel Specialties delivers chemical additives that enhance performance in automotive, marine, aviation, and power generation engines, as well as heating oil. Performance Chemicals provides tailored solutions for personal care, home care, agrochemical, and metal extraction markets. Oilfield Services provides chemical solutions for fracturing, stimulation, and completion operations, as well as products that enhance oil and gas production efficiency and prevent drilling mud loss. Headquartered in Englewood, Colorado, the business was founded in 1938 as Octel Corp.

Over the five-year period from FY2020 to FY2025, Innospec achieved a revenue CAGR of 8.3%. Annual revenue expanded to $1.96B in FY2022 before contracting to $1.95B in FY2023, $1.85B in FY2024, and $1.78B in FY2025, which marked a 3.7% decline. Net income rebounded to $116.6M in FY2025 with an EPS of $5.30, up from $35.6M and an EPS of $5.90 in FY2024. In the trailing twelve months, revenue reached $1.84B with an operating margin of 8.1% and a profit margin of 6.6%. In the latest quarter ended June 30, 2026, quarterly revenue grew 11.8% year-over-year and quarterly earnings rose 33.0%.

As of June 30, 2026, Innospec held $250.2M in cash and short-term investments against total debt of $47.9M, leaving net cash of $202.3M. The company shows a debt-to-equity ratio of 0.04 and a current ratio of 2.78, backed by $1.34B in shareholders' equity. In FY2025, operating cash flow reached $138.3M and free cash flow stood at $88.0M. Capital deployment in FY2025 included $50.3M for capital expenditures, $42.4M for dividends, and $23.9M for share buybacks.

IOSP trades at a trailing P/E of 19.8x, compared to 19.7x for the median of its US-listed Basic Materials peers. Its forward P/E is 15.0x versus the peer median of 13.4x, and its EV/EBITDA stands at 11.4x compared to the peer median of 10.5x. However, its price-to-sales of 1.3x sits below the peer median of 1.8x. Over the past year, Innospec returned 33.6%, outperforming the S&P 500 (SPY) return of 16.8%, while its five-year return of 22.1% trailed the S&P 500 return of 83.0%.

Innospec pays a semiannual dividend with an annualized forward payout of $1.79 per share, reflecting a 1.85% dividend yield and a payout ratio of 36.2%. The company has paid dividends for 15 consecutive years, achieving a 5-year annualized dividend growth rate of 10.5%. The last ex-dividend date was May 19, 2026.

Wall Street coverage on Innospec includes 2 Strong Buy ratings and 1 Buy rating, with no Hold, Sell, or Strong Sell ratings. The mean price target is $101.00, representing a 4.3% premium over the last close of $96.81. For the current fiscal year ending December 31, 2026, analysts expect revenue of $1.91B and EPS of $4.92, which implies an EPS contraction of 6.6%. For the next fiscal year, 3 analysts project revenue of $2.02B and EPS of $6.17. Innospec beat EPS estimates in all of the last 4 quarters, with next earnings scheduled for November 3, 2026.

This page is an AI-written research summary of Innospec Inc. (IOSP). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: IOSP income statement, IOSP balance sheet, IOSP key metrics, IOSP analyst forecast, IOSP chart. See the IOSP stock overview for the latest quote and news.